MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan is a pharmaceutical composition containing antibody agent conjugate (ADC) . (extracted from patent WO2021190581 Example 1-8) [1].
Product Specifications
CAS Number
[2414254-41-2]
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC; Topoisomerase
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mc-gly-gly-phe-gly-amide-cyclopropanol-amide-exatecan.html
Purity
99.16
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C1(CC1)OCNC(CNC([C@@H](NC(CNC(CNC(CCCCCN2C(C=CC2=O)=O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)N[C@@H]4C5=C6C(C(N7C6)=CC([C@](O)(C(OC8)=O)CC)=C8C7=O)=NC9=CC(F)=C(C)C(CC4)=C95
Molecular Formula
C54H58FN9O13
Molecular Weight
1060.09
References & Citations
[1]Yue Zhanlong, et al. Pharmaceutical composition comprising antibody drug conjugate and use thereof. WO2021190581A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Camptothecins
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV669098 1.0 µg DNA
NPY Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 
MBS6475184-01 0.1 mL
EIF2AK1, NT (Eukaryotic Translation Initiation Factor 2 alpha Kinase 1, Heme-regulated Eukaryotic Initiation Factor eIF-2-alpha Kinase, Heme-regulated Inhibitor, Heme-controlled Repressor, HCR, Hemin-sensitive Initiation Factor-2 alpha Kinase, PRO1362, HR
Sign In for Pricing
View Details